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Background: HLA genotyping by next generation sequencing (NGS) requires three basic steps, PCR, NGS, and allele
assignment. Compared to the conventional methods, such as PCR-sequence specific oligonucleotide primers (SSOP)
and -sequence based typing (SBT), PCR-NGS is extremely labor intensive and time consuming. In order to simplify
and accelerate the NGS-based HLA genotyping method for multiple DNA samples, we developed and evaluated
four multiplex PCR methods for genotyping up to nine classical HLA loci including HLA-A, HLA-B, HLA-C,
HLA-DRB1/3/4/5, HLA-DQB1, and HLA-DPB1.
Results: We developed multiplex PCR methods using newly and previously designed middle ranged PCR
primer sets for genotyping different combinations of HLA loci, (1) HLA-DRB1/3/4/5, (2) HLA-DQB1 (3.8 kb to
5.3 kb), (3) HLA-A, HLA-B, HLA-C, and (4) HLA-DPB1 (4.6 kb to 7.2 kb). The primer sets were designed to genotype
polymorphic exons to the field 3 level or 6-digit typing. When we evaluated the PCR method for genotyping all nine
HLA loci (9LOCI) using 46 Japanese reference subjects who represented a distribution of more than 99.5% of the HLA
alleles at each of the nine HLA loci, all of the 276 alleles genotyped, except for HLA-DRB3/4/5 alleles, were consistent
with known alleles assigned by the conventional methods together with relevant locus balance and no excessive allelic
imbalance. One multiplex PCR method (9LOCI) was able to provide precise genotyping data even when only 1 ng of
genomic DNA was used for the PCR as a sample template.
Conclusions: In this study, we have demonstrated that the multiplex PCR approach for NGS-based HLA genotyping
could serve as an alternative routine HLA genotyping method, possibly replacing the conventional methods
by providing an accelerated yet robust amplification step. The method also could provide significant merits
for clinical applications with its ability to amplify lower quantity of samples and the cost-saving factors.* Correspondence: tshiina@is.icc.u-tokai.ac.jp
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The Human Leukocyte Antigen (HLA) or the Major
Histocompatibility Complex (MHC) is a highly poly-
morphic region of the human genome (on the short arm
of chromosome 6) that is critically involved in the rejection
and graft-versus-host disease (GVHD) of hematopoietic
stem cell transplants [1,2], the pathogenesis of numerous
autoimmune diseases [3-6], infectious diseases [7] and
drug adverse reactions [8,9]. Many variations of the con-
ventional HLA genotyping methods such as incorporating
restriction fragment polymorphisms (RFLP) [10], single
strand conformation polymorphism (SSCP) [11], sequence
specific oligonucleotides (SSOs) [12], sequence specific
primers (SSPs) [13] and sequence based typing (SBT), like
the Sanger method [14], have been used for the efficient
and rapid HLA matching in transplantation therapy
[15-18], research into autoimmunity and HLA related dis-
eases [19,20], population diversity studies [21-23] and in
forensic and paternity testing [24]. The HLA genotyping
methods mainly applied today are PCR-SSOP, such as the
Luminex commercial methodology [25,26], and SBT by
the Sanger method employing capillary sequencing based
on chain-termination reactions [14,27]. However, both
methods often detect more than one pair of unresolved
HLA alleles because of chromosomal phase (cis/trans)
ambiguity [28-30]. To solve the phase ambiguity problem,
we previously reported the development and application
of the super high resolution-single molecule-sequence-
based typing (SS-SBT) method using long-range PCR of
the sample DNA from the promoter-enhancer region to
the 3′ untranslated region (3′UTR) for 11 classical HLA
loci, HLA-A, HLA-B, HLA-C, HLA-DRB1, HLA-DRB3/
4/5, HLA-DQA1, HLA-DQB1, HLA-DPA1, and HLA-
DPB1 in combination with next generation sequencing
(NGS) platforms such as Ion PGM (Life Technologies)
and GS Junior (Roche) [31-33]. Other long-range PCR
and NGS-based HLA genotyping methods using 454 GS-
FLX (Roche) and MiSeq (Illumina) platforms [30,34-36]
also resolved the phase ambiguities. Thus, the NGS
methods combined with the long-range PCR technology
are expected to produce genotyping results to the field 4
level (formerly known as 8-digit typing) allelic resolution
to efficiently detect new and null alleles without phase
ambiguity.
The NGS methods are usually divided into three basic
steps, long-range PCR of the DNA samples, NGS, and
allele assignment step (Figure 1A) [25]. Before performing
the NGS step there are at least five sub-steps for PCR,
such as preparation of DNA template and PCR mixes, the
PCR runs, electrophoresis, purification, and quantitative
determination of the PCR products (Figure 1B). Multiple
micro-tubes are required for the singleplex PCR. For ex-
ample, at least six micro-tubes are required to amplify
nine loci per DNA sample (Figure 1B). At least two kindsof NGS library preparation processes can be used after
performing the long-range singleplex PCR procedure.
One process is to prepare a number of single locus tagging
NGS libraries and then pool all of them into a single
NGS library (singleplex PCR/singleplex NGS library
model: Figure 1B (1)). The other process is to pool all of
the PCR products and prepare a single NGS library for
each of the tagged multiple loci as a multiplex NGS library
(singleplex PCR/multiplex NGS library model: Figure 1B
(2)). However, the long-range singleplex PCR amplifica-
tion and NGS library preparation as outlined in Figures 1B
(1) and B (2) are extremely labor intensive and time con-
suming. Furthermore, it is easy to make human errors at
the pooling stage that negatively influence the sequence
read numbers. Therefore, simplification, acceleration and
cost-saving in the NGS protocols are required if they are
to become routine DNA typing methods and replace the
conventional HLA genotyping methods such as SBT and
PCR-SSOP (e.g. Luminex methodology).
In this paper, we describe the development and evalu-
ation of four types of multiplex PCR methods that geno-
type multiple HLA loci to the field 3 level (6-digit typing)
using combinations of locus specific PCR primers for up
to nine classical HLA loci (HLA-A, HLA-B, HLA-C,
HLA-DRB1/3/4/5, HLA-DQB1, and HLA-DPB1). We
evaluated the uniformity and accuracy of NGS-based
HLA genotyping among the nine HLA loci and between
HLA alleles obtained by one of the multiplex PCR
methods (the nine loci [9LOCI] multiplex method) in a
single NGS run with the Ion PGM sequencer using 46
genomic DNA reference samples from Japanese subjects
who represented a distribution of more than 99.5% HLA
alleles in each of the HLA locus in the Japanese popula-
tion. In addition, we investigated template DNA amounts
as low as 1 ng to evaluate the smallest amounts of gen-
omic DNA samples that we could use successfully in our
multiplex PCR methods for NGS-based HLA genotyping.
Results
Characteristics of four types of multiplex PCR methods
Four types of multiplex PCR methods were developed
after optimization of primer composition and PCR con-
ditions such as annealing and extension temperatures
using the HLA-A, HLA-B, HLA-C, HLA-DRB1/3/4/5,
HLA-DQB1, and HLA-DPB1 specific primer pair sets
(Figure 2). These four types were CI: A/B/C, CII: DRB1/
3/4/5/DQB1/DPB1, 7LOCI: A/B/C/DRB1/3/4/5, and
9LOCI: A/B/C/DRB1/3/4/5/DQB1/DPB1. Two, three,
three, and four bands that reflect the targeted PCR prod-
ucts were observed in CI, CII, 7LOCI, and 9LOCI multi-
plex PCR methods, respectively. Although most of the
bands overlapped because of their similar PCR lengths
as for HLA-B and HLA-C in CI (Figure 2A), it is note-
worthy that HLA-A in CI (Figure 2A), and HLA-DPB1
Figure 1 Workflow by the Ion PGM sequencer (A) and three different nine loci HLA genotyping procedures by PCR and NGS (B). White and gray
boxes indicate experimental steps using either several micro-tubes or a single micro-tube, respectively. Numbers in micro-tubes indicate template
DNA amounts (ng).
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Figure 2 Band patterns of the multiplex PCR products. Electrophoresis images of PCR products from four unrelated genomic DNA samples
(labeled 1 to 4) using four types of multiplex PCR methods, CI (A), CII (B), 7LOCI (C) and 9 LOCI (D), respectively. Numbers 1 to 4 above the lanes
indicate genomic DNA samples WW035, WW090, WW102, and WW104, respectively. The lanes labeled M are bands of the 1 kb DNA size marker
ladder. The size of the bands and the HLA loci amplified by PCR are indicated on the right side of the figure.
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as unique bands. In addition, the PCR product from the
HLA-DRB1 gene varies in size depending on the DR
sub-type such as 5.2 kb in the DR4 sub-type and 4.0-
4.1 kb in the other DR sub-types.
When we applied the nine loci multiplex PCR (9LOCI)
method using 46 genomic DNA samples (JPN01 to JPN46),
the PCR products with similar band patterns were ob-
served in all samples, although weak bands were also ob-
served in some samples such as JPN23, JPN24, JPN25,
and JPN29 (Additional file 1: Figure S1).
Sequence read information obtained from 46 genomic
DNA samples
Sequence read information was obtained for all the 46
genomic DNA samples after sequencing of the 9LOCI
products using the Ion PGM system in a single sequen-
cing run after gathering the 46 barcode-labeled DNA li-
braries into one tube. Draft read numbers in total were
5,284,570 sequence reads with a range of reads from
83,680 in JPN21 to 156,157 sequence reads in JPN45
(114,882 ± 20,482 standard deviation (SD) on average)that were high quality sequence reads with more than 10
quality values (QV) and an average QV of 28.0 ± 0.2 in
the high quality sequence reads. The draft read bases in
total were 1,447 Mb with a range between 21.7 Mb in
JPN021 and 43.4 Mb in JPN041 (31.4 ± 6.0 Mb on aver-
age), with an overall average read length of 273.3 ± 9.9
bases and an overall mode read length of 358.6 ± 16.7
bases (Additional file 2: Table S1). Therefore, the sequence
reads had high quality and sufficient sequence volume for
further HLA genotyping analysis.
Genotyping to the field 3 level on the nine HLA loci
Nucleotide similarity searches of the sequenced HLA al-
leles to the field 3 level using the BLAT program identi-
fied 276 alleles at the six HLA loci (Additional file 3:
Table S2), except for DRB3/4/5, that were consistent with
known HLA alleles assigned by the conventional Luminex
method (Additional file 4: Table S3). Of the heterozygous
242 alleles, 224 were defined as two separate HLA alleles
without any ambiguities. However, one locus observed in
JPN15 (DPB1*05:01:01/DPB1*135:01 and DPB1*25:01)
was not defined fully due to the absence of an informative
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sign the correct allele at the locus. Also, five types of
ambiguous HLA alleles, such as DRB1*04:07:01/*04:92,
DRB1*04:10:01/*04:10:03, DRB1*09:01:02/*09:21, DRB1*
12:01:01/*12:10, and DPB1*13:01/*107:01 at a total of 17
loci, were observed because the informative SNPs that
differentiate between ambiguous alleles were located out-
side of the PCR regions such as within exon 1 or exon 4
of HLA-DRB1 or HLA-DPB1 (Additional file 3: Table S2).
From the results of genotyping to the field 3 level, five
HLA-DRB3, three HLA-DRB4, and three HLA-DRB5 al-
leles were assigned in the 45 DNA samples (Table 1 and
Additional file 3: Table S2). There were thirty DRB1-DRB3/
4/5 haplotypes in total with 15 assigned as the DRB1-DRB3Table 1 DRB1-DRB3/4/5 haplotypes to the field 3 level
DR haplotype DR type DRB1 type DRB1 - D
DRB1 alle



























DR51 DR2 DR15 DRB1*15:0
DR15 DRB1*15:0
DR16 DRB1*16:0
*Bold letter indicates allele assigned by published long-range PCR system [31].haplotype, 12 as DRB1-DRB4, and three as DRB1-DRB5.
These haplotypes were identified by estimating HLA-DRB1
and HLA-DRB3/4/5 alleles without any descrepancy to pre-
viously reported DRB structures [32,37].
Moreover, mapping analysis including other exons and
introns using the SEABASS program suggested that no
recombinations were evident within the gene loci examined
for the 46 genomic samples (data not shown). Through
this process one synonymous substitution was newly de-
tected in exon 4 of HLA-C*07:04 of JPN16.
Evaluation of the 9LOCI multiplex PCR method
To evaluate the 9LOCI method, we compared the depth
































Figure 3 Locus balance depth plot based on normalized average
depth per allele. White and black dots indicate normalized depth
per locus in each DNA sample and normalized depth on average,
respectively. The Y-axis of the plot shows the units of sequence
depth and the X-axis shows the HLA gene loci. The detailed
information is provided in Additional file 5: Table S4.
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average depth and range for six HLA loci was as follows:
78.5 ± 42.0 from 31.6 to 225.1 for HLA-A, 116.5 ± 51.1
from 33.7 to 341.8 for HLA-B,130.0 ± 59.3 from 62 to
331.3 for HLA-C, 209.1 ± 115.9 from 44.1 to 712.4 for
HLA-DRB1, 194.7 ± 104.9 from 74.9 to 614.4 for HLA-
DQB1, and 59.2 ± 34.6 from 25.3 to 161.4 for HLA-
DPB1 (Table 2 and Additional file 5: Table S4). The aver-
age depth ratio was mostly even for both alleles, ranging
from 0.9 ± 0.3 in HLA-DRB1 to 1.0 ± 0.1 in HLA-A, but
allelic imbalances of 0.2-0.5 were observed in eight DNA
samples of HLA-B and 16 DNA samples of HLA-DRB1
(Additional file 5: Table S4). Most of the loci contained
specific HLA allele groups such as B*39 and DRB1*04.
On the other hand, an observed average depth among
the HLA locus was from 116.3 ± 42.6 in HLA-DPB1
to 418.3 ± 143.0 in HLA-DRB1. When we normalized
the values using the average sequence read numbers
(114,882 reads), the depth was from 118.4 ± 37.8 in
HLA-DPB1 to 416.7 ± 114.3 in HLA-DRB1 (Table 2).
A locus balance plot showed locus imbalance among the
loci ranging from high at HLA-DRB1 and HLA-DQB1 to
low at HLA-A and HLA-DPB1 (Figure 3). However, the
genotypes obtained at all the loci (276 alleles) in this study,
were consistent with known HLA alleles to the field 3 level
with more than 25 depth units per allele in DPB1*05:01:01
of JPN39, suggesting that the locus balance completely
made up for the allelic imbalances observed for some spe-
cific alleles. Taken together, the 9LOCI PCR and NGS is a
precise HLA genotyping method with relevant locus bal-
ance and without excessive allelic imbalance (<0.2) affect-
ing the results deleteriously.
Investigation of template DNA amounts for the 9LOCI
method
In order to achieve precise HLA genotyping for the
9LOCI method even with using extremely small amounts
of genomic DNA samples, we tried the 9LOCI multiplex
PCR using four different amounts of template DNA, 1 ng,
5 ng, and 10 ng, along with standard amount of 25 ng.
Amplified PCR products were observed for all of the tem-
plate DNA amounts ranging from 1 to 25 ng (Figure 4).Table 2 Depth information of each allele and each locus
Locus Average depth (average ± SD) Average depth ra
Observed Normalized*
HLA-A 78.5 ± 42.0 78.2 ± 37.9 1.0 ± 0.1
HLA-B 116.5 ± 51.1 117.8 ± 46.8 0.9 ± 0.2
HLA-C 130.0 ± 59.3 127.4 ± 55.8 0.9 ± 0.1
HLA-DRB1 209.1 ± 115.9 208.4 ± 108.2 0.9 ± 0.3
HLA-DQB1 194.7 ± 104.9 194.4 ± 95.3 0.9 ± 0.1
HLA-DPB1 59.2 ± 34.6 59.2 ± 31.3 0.9 ± 0.1
*calculated using the average draft read number (114,882 reads) shown in AdditionThe DNA amounts after purification of the PCR products
ranged from 119.7 ng (1 ng template) to 608.6 ng (25 ng
template) in TU5, and from 112.5 ng (1 ng template) to
559.7 ng (25 ng template) in TU6. The purified PCR prod-
ucts of 100 ng were used for construction of Ion PGM
libraries. The molarities after construction of Ion PGM li-
braries ranged from 8,444 pM (5 ng template in TU5) to
26,772 pM (25 ng template in TU5), and the sequence
read numbers ranged from 329,752 (1 ng template in
TU5) to 651,450 (25 ng template in TU6). The genotype
results obtained for the eight samples used in this test of
template DNA amounts were consistent to the previously
assigned HLA alleles [31].
Discussion
In this study, we used a reference set of 46 Japanese sub-
jects that represented a distribution of more than 99.5%
of the Japanese HLA alleles at the nine HLA loci geno-
typed by the multiplex PCR-NGS method using the Iontio (average ± SD)* Average depth per locus (average ± SD)
Observed Normalized*
156.9 ± 48.5 156.3 ± 36.2
233.0 ± 75.2 235.6 ± 68.2
257.1 ± 90.9 255.4 ± 71.3
418.3 ± 143.0 416.7 ± 114.3
389.3 ± 115.9 388.9 ± 100.4
116.3 ± 42.6 118.4 ± 37.8
al file 2: Table S1.
Figure 4 Electrophoresis images of PCR products from two
unrelated genomic DNA samples TU05 and TU06 using the 9LOCI
method. Numbers 1 to 4 above the lanes indicate the template DNA
amounts 25 ng, 10 ng, 5 ng, and 1 ng, respectively. The lanes
labeled M are bands of the 1 kb DNA size marker ladder.
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and DRB3/4/5 alleles were consistent with known alleles
(Additional file 3: Table S2) and previous publications
[32,37], suggesting that a combination of our multiplex
PCR methods and the Ion PGM system is an efficient
and accurate HLA genotyping method for the detection
of HLA alleles to the field 3 level of genotyping without
phase ambiguity. In addition, PCR products were ob-
tained from all of the HLA loci by the multiplex PCR-
NGS methods in tests using 400 non-Japanese (mainly
European), subjects, confirming that the methods will be
useful for the Japanese as well as for other world-wide
populations (data not shown).
The high density in the average depth of sequences by
NGS suggests that an increase in the DNA sample num-
bers for sequencing beyond 46 per run as described here
is likely to contribute to even lower costs. For example,
85,879 sequence reads for sample JPN33 that was imbal-
anced at DRB1*04:06:01 was assigned with a sequence
depth of 58.9. When we assume that an average of 85,879
sequence reads was obtained from a total of 5,284,570
reads that have a similar quality to those described in
Additional file 2: Table S1, then at least 61 DNA samples
could have been genotyped in a single run using Ion
PGM. The multiplex PCR methods for HLA genotyping
could also be used on other NGS platforms such as MiSeq
(illumina), GS Junior and 454 GS-FLX (Roche), as well as
on the 3rd generation sequencing platform PacBio RS
(Pacific Bioscience) that is based on single molecule real-
time (SMRT) technology (unpublished data).
Although, a few samples like JPN15 (DPB1*05:01:01/
DPB1*135:01 and DPB1*25:01) were not fully resolved
by the multiplex PCR-NGS method, this problem could
be solved in future by determining the full gene nucleo-
tide sequence for the DPB1 gene with the *25:01 allele.
Hence, it is necessary to comprehensively collect the
HLA allele sequences for all of the PCR regions of all
the HLA genes to avoid misidentifying the true locus
because of potential problems of allele sharing be-
tween different loci or PCR amplification of sequences
in the wrong gene regions. In this study, only fiveambiguous HLA alleles, DRB1*04:07:01/*04:92, DRB1*04:10:01/
*04:10:03, DRB1*09:01:02/*09:21, DRB1*12:01:01/*12:10,
and DPB1*13:01/*107:01, were observed at 17 loci. In
these cases, the ambiguities were not solved because the
informative SNPs for these genes are outside of the PCR
regions such as in some of the introns or the 5′ and 3′
non-coding regions or because the informative SNPs that
differentiate between ambiguous alleles are located outside
of the PCR regions such as within exon 1 or exon 4 of
HLA-DRB1 or HLA-DPB1 (Figure 5). It is noteworthy,
however, that there was no problem with phase ambiguity
for more than 99% of the HLA alleles detected by the
9LOCI method that included the signature sequences of
the highly polymorphic exon 2 that play an important
role for antigen presentation. Therefore, the multiplex
PCR-NGS HLA genotyping method that we have de-
scribed here is highly effective, accurate and informative
and provides an important alternative to the conventional
HLA genotyping methods such as SBT and PCR-SSOP
that are currently in use in the clinical laboratory. When
we applied our previously published long-range PCR
primer sets for the ambiguous loci [31], DPB1*05:01:01
and DPB1*25:01, DRB1*04:07:01, DRB1*04:10:03, DRB1*
09:01:02, DRB1*12:01:01, and DPB1*13:01 were assigned
without ambiguity. These alleles were consistent with
known HLA alleles previously assigned by the con-
ventional methods (Additional file 4: Table S3).
To evaluate the sequencing parameters for the 9LOCI
PCR-NGS method, we compared the sequencing depth
derived from the sequence read numbers between HLA
alleles and among HLA loci. The lowest observed aver-
age depth (59.2 ± 34.6) was for HLA-DPB1 among the
six loci with more than a read depth of 25 (Table 2),
where a depth of at least 30 is necessary to identify gen-
etic variants with the highest sensitivity and resolution
[38]. In this respect, it will be necessary to improve the
sequence reads of HLA-DPB1 by further optimization of
primer composition.
In contrast to the one simple multiplex PCR step that
is required for the 9 HLA loci, the singleplex PCR
models described in Figure 1B (1) and B (2) require
many more repetitive steps to amplify the 9 HLA loci
and at least five complicated PCR steps for each locus
such as preparation of PCR reagents and DNA tem-
plates, long range singleplex PCR, electrophoresis, puri-
fication, and quantitative determination of the PCR
products before preparing the single locus tagging NGS
libraries and pooling of all libraries (singleplex PCR/sin-
gleplex NGS library model, Figure 1B (1)), and/or before
pooling of all PCR products and preparing the multiple
locus tagging NGS libraries (singleplex PCR/multiplex
NGS library model, Figure 1 (2)). As a more efficient,
economical and rapid alternative to the time-consuming
singleplex PCR of HLA loci, we developed four types of
Figure 5 Outline of the targeted PCR regions in nine HLA loci. Black, gray and white boxes indicate promoter regions, highly polymorphic exons
and the other exons, respectively.
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for NGS-based HLA genotyping of polymorphic exons.
All of the four types of multiplex PCR methods are
useful for the HLA genotyping (this study and data not
shown), but the 9LOCI method is likely to be the more
valuable method for future routine genotyping for the
following reasons and technical advantages. (1) The
9LOCI genotyping method is capable not only for typing
the specific HLA loci such as HLA-A, HLA-B, and
HLA-DRB1, but also other classical HLA loci such as
HLA-C, HLA-DRB3/4/5, HLA-DQB1, and HLA-DPB1
at the same time (Additional file 3: Table S2). (2) The
running cost and operation time for the PCR step in the
9LOCI method were reduced to one sixth of the single-
plex PCR models. The use of only one micro-tube per
sample for the PCR and NGS steps is time-saving and
economically helpful for cost-savings on micro-tubes,
DNA polymerase and other reagents, and it also elimi-
nates the pooling operations (Figure 1B (3)). If the quan-
tity of all template DNA samples is adjusted accurately
among the samples, then electrophoresis of the samples
also could be omitted because the PCR products are
quantified by the PicoGreen assay after their purifica-
tion. Thus, omission of some processes such as the pool-
ing step that can influence the sequence read numbers
could help to a further reduce potential human experi-
mental errors. (3) The PCR step of multiplex 9LOCI
PCR-NGS method for 46 DNA samples was performed
in one day. In comparison, the singleplex methods using
46 DNA samples for each of the nine HLA loci would
have taken at least three days. (4) Investigation of the
template DNA amount suggested that 1 ng of template
DNA is sufficient for genotyping all nine HLA loci by
the 9LOCI method (Figure 4). The 1 ng amount for the
multiplex method is much less than that required for
the singleplex PCR methods (Figure 1A (1) and B (2)),and therefore markedly reduced the progressive loss of
valuable DNA samples that are required for genotyping
of nine HLA loci. This small DNA amount also could be
helpful for DNA typing from swab samples derived from
oral mucosa cells, FACS derived lymphoma cells and
other valuable clinical samples. (5) Therefore, the multi-
plex PCR method for the nine HLA loci greatly simpli-
fies the procedures required in preparing the DNA
samples for NGS by reducing the time of preparation
and the amount and costs of reagents, including the use
of much smaller amounts of template DNA samples. In
addition, the use of different NGS methods might further
improve the simplicity and cost of the multiplex PCR-NGS
method in the future. For example, a new protocol using
Ion Isothermal Amplification Chemistry that enables se-
quence reads of up to and beyond 500 bp, and Ion Hi-Q™
Sequencing Chemistry that reduces consensus insertion
and deletion (indel) errors including homopolymer errors
will be available in the near future (personal communica-
tion with Life Technologies), and might lead to further
simplification and cost reduction with higher data quality.
Conclusions
Our aim was to simplify and streamline the NGS-based
HLA genotyping method as an alternative to the con-
ventional HLA genotyping methods. Although 46 gen-
omic DNA samples were used in the present study as an
example of using multiple samples in a single genotyping
run, we have recently applied the same methods for
genotyping more than 500 DNA samples from Japanese,
Indian and French populations in a number of different
genotyping runs to unequivocally define the HLA-A,
HLA-B, HLA-C, HLA-DRB1/3/4/5, HLA-DQB1, and
HLA-DPB1 loci to single HLA alleles to the field 3 level
without ambiguity. Therefore, the multiplex PCR methods
have contributed greatly to simplify, accelerate and reduce
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HLA genotyping method. The methods also conserve
on the amounts of DNA samples needed to genotype
a multiple number of HLA loci. Overall, the multiplex
PCR methods are a powerful tool that provides precise
genotyping data without phase ambiguity and with a po-
tential to replace the current routine genotyping methods
to find polymorphisms. These methods may help to fur-
ther activate many fields of medical research involved in
the studies of transplantation, disease association, drug ad-
verse reaction, peptide vaccination treatment for cancer
and provide us with a better understanding about the di-
versity and evolution of the human MHC.
Methods
Genomic DNA samples
A total of 3,115 donors for bone marrow transplantation
through the Japan Marrow Donor Program (JMDP) be-
tween 2006 and 2010 were retrospectively genotyped for
HLA-A, HLA-B, HLA-C, HLA-DRB1, HLA-DQB1, and
HLA-DPB1 alleles to the field 2 level (4-digit typing) as
described elsewhere [39]. Of these genotyped donor sam-
ples, 46 genomic DNA samples (JPN01 to JPN46) were
selected as a reference set based on the distribution of
the HLA allele frequency data in the Japanese population
(HLA laboratory: http://www.hla.or.jp/haplo/haplonavi.
php?type=aril&lang=en) (Additional file 6: Table S5).
The reference samples represented more than 99.5% of
HLA alleles at each HLA locus with 99.6% at HLA-A,
99.6% at HLA-B, 99.7% at HLA-C, 99.8% at HLA-DRB1,
100% at HLA-DQB1, and 99.9% at HLA-DPB1. In this
regard, the reference set included 18 HLA-A alleles,
37 HLA-B alleles, 18 HLA-C alleles, 31 HLA-DRB1 al-
leles, 14 HLA-DQB1 alleles, and 18 HLA-DPB1 alleles
(Additional file 7: Table S6). In addition, approximately
200 genomic DNA samples collected from populations in
Africa and Europe were used for an initial study of the
optimization of the multiplex PCR methods demonstrat-
ing that the method works for various worldwide popula-
tions as well as for Japanese. The Japanese HLA genotyping
results using the Luminex method are shown in Additional
file 4: Table S3. Informed consents were obtained from do-
nors in accordance with the Declaration of Helsinki, and
the study protocol was approved from the institutional re-
view board of JMDP and Tokai University.
PCR primer designation and multiplex PCR amplification
To develop multiplex PCR systems we used previously
designed HLA-A, HLA-B, HLA-C, and HLA-DPB1
locus-specific primer sets that cover the whole gene re-
gions from the promoter-enhancer region to 3′UTR
with the product size of 5.5 kb in HLA-A, 4.6 kb in
HLA-B, and 4.8 kb in HLA-C, and from intron 1 to 3′
UTR with the product size of 7.2 kb in HLA-DPB1 [31].Also, we newly designed an HLA-DRB1/3/4/5 DRB-
specific primer set and an HLA-DQB1 locus-specific pri-
mer set (available upon request) that cover polymorphic
exons (exons 2 and 3) from intron 1 to exon 4 with the
product size of 4.0-5.2 kb in HLA-DRB1, 4.1 kb in
HLA-DRB3, 4.5 kb in HLA-DRB4, 4.1 kb in HLA-DRB5,
and 3.9-4.3 kb in HLA-DQB1 based on the genomic se-
quences released from GenBank/EMBL/DDBJ DNA data-
bases (accession numbers NG_002392, NG_002433, and
NG_002432) and conserved regions of 1000 genome se-
quences (http://www.1000genomes.org/) (Figure 5). Multi-
plex PCR methods were constructed using the primer sets
by carefully optimizing primer composition and PCR con-
ditions and by comparing to sequence read data from NGS
(data not shown).
For PCR amplification of the multiplex PCR methods,
the 20 μL PCR amplification-reaction-volume contained
1–25 ng of genomic DNA, 1 unit of PrimeSTAR GXL
DNA polymerase (TaKaRa Bio, Shiga, Japan), 4.0 μL of 5 ×
PrimeSTAR GXL Buffer (5 mM Mg2+), 1.6 μL of 2.5 mM
of each dNTP and 3.2-5.1 μL (10 pmol/μL) of each primer
mixture. The cycling parameters were as follows: pri-
mary denaturation 94°C/2 min., followed by 30 cycles for
98°C/10 sec. and 70°C/4 min. The PCR reactions were
performed using the thermal cycler GeneAmp PCR sys-
tem 9700 (Applied Biosystems/Life Technologies/Thermo
Fisher Scientific, Foster City, CA). The DNA size was mea-
sured by using a 1 kb DNA ladder marker (New England
BioLabs, Ipswich, MA). The PCR products were puri-
fied by the Agencourt AMPure XP (Beckman Coulter,
Fullerton, CA) and quantified by the PicoGreen assay
(Invitrogen/Life Technologies/Thermo Fisher Scientific,
Carlsbad, CA) with a Fluoroskan Ascent micro-plate
fluorometer (Thermo Fisher Scientific, Waltham, MA).
NGS using Ion Torrent PGM system
Barcoded-library DNA samples were prepared with an
Ion Xpress Plus Fragment Library Kit and Ion Xpress bar-
code Adaptors 1–96 Kit according to the manufacturer’s
protocol for 400 base-read sequencing (Life Technologies/
Thermo Fisher Scientific, Palo Alto, CA). One hundred
nanograms of the multiplex PCR products were used for
the preparation of each DNA library. DNA samples were
fragmented with a M220 Focused-ultrasonicator (Covaris,
Woburn, MA). Each DNA library was amplified by eight
cycles of PCR. The DNA size and quantitation for each
library was measured by an Agilent 2100 Expert Bioanalyzer
using the Agilent High Sensitivity DNA Kit (Agilent
Technologies, Santa Clara, CA). Each barcoded-library
was mixed at equimolar concentrations then diluted ac-
cording to the manufacturer’s recommendation. Emulsion
PCR (emPCR) was performed using the resulting pooled
library with the Ion PGM Template OT2 400 Kit on an
Ion OneTouch 2 automated system (Life Technologies)
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ation 95°C/10 min., followed by 20 cycles for 95°C/30 sec.,
66°C/4 min., 20 cycles for 95°C/30 sec., 66°C/6 min. and
10 cycles for 95°C/30 sec., and 66°C/20 min. After the
emulsion was automatically broken with the OneTouch 2
instrument, the beads carrying the single-stranded DNA
templates were enriched according to the manufacturer’s
recommendation. Sequencing was performed using the
Ion PGM Sequencing 400 Kit and Ion 316 and 318 Chip
Kit v2 with a flow number of 850 for 400 base-read [40].
Data processing and allele assignment
The raw data processing and base-calling, trimming and
output of quality-filter sequence reads that were binned
on the basis of the Ion Xpress Barcodes into 46 separate
sequence fastq files, were all performed by the Torrent
Suite 4.2.1 software (Life Technologies) with full pro-
cessing for shotgun analysis. These files were further
quality trimmed to remove poor sequence at the end of
the reads with QVs of less than 10. The trimmed and
barcode-binned sequence reads were used for HLA allele
assignment to the field 3 and 4 levels by Sequence
Alignment Based Assigning Software (SeaBass) (an in-
house development of Tokai University, in preparation).
HLA allele candidates and/or reference sequences used
for mapping of the sequence reads were selected by
nucleotide similarity searches with HLA allele sequences
in the IMGT-HLA database using the BLAT program
(http://genome.ucsc.edu/), and thereafter, mapping of
the sequence reads and the selected reference sequences
were performed automatically with the GS Reference
Mapper Ver. 3.0 software (Life Technologies). The map-
ping parameter was set to a perfectly matched condition
between the read sequences and the reference sequences
to avoid mismapping among the HLA loci and contamin-
ation of in vitro generated PCR crossover products [41]. If
a reference sequence covering the PCR region was not
available, we constructed a new virtual sequence by de
novo assembly using the Sequencher Ver. 5.0.1 DNA se-
quence assembly software (Gene Code, Ann Arbor, MI),
and used it as a reference sequence.
Calculation of uniformity among HLA loci and between
HLA alleles
After assignment of the HLA alleles we calculated uni-
formity among the HLA loci and between alleles using
the sequence reads that separated to each allele. The
read depth is the number of individual sequence reads
that align to a particular nucleotide position [25]. An aver-
age depth of exons 2 and 3 in class I loci, HLA-A, HLA-B,
and HLA-C, and exon 2 in class II loci, HLA-DRB1,
HLA-DQB1, and HLA-DPB1, was calculated as an aver-
age redundancy per nucleotide site (the sum of depth on
all nucleotide site numbers/nucleotide site numbers).Average depth ratio was calculated as an average depth of
one allele/large average depth of the other allele. Depth
per locus was calculated by the sum of average depth of
both alleles.Additional files
Additional file 1: Figure S1. Electrophoresis images of PCR products
from 46 genomic DNA samples JPN01 to JPN46 using the 9LOCI method.
The short description of the data: Electrophoresis images of PCR products
from 46 genomic DNA samples (JPN01 to JPN46) were shown in the
figure. The HLA loci in the bands amplified by PCR are indicated on the
right side of the figure.
Additional file 2: Table S1. Sequence read information obtained by
the Ion PGM system. The short description of the data: Draft read
numbers, draft read bases, average read length, mode read length, and
average quality value of sequence reads derived from 46 DNA samples.
Additional file 3: Table S2. Alleles for nine HLA loci obtained by the
9LOCI genotyping method. The short description of the data: Genotypes
of nine HLA loci obtained by the 9LOCI method.
Additional file 4: Table S3. HLA alleles for 46 Japanese DNA samples
using the Luminex genotyping method. The short description of the
data: A list of HLA genotypes of 46 DNA samples used in this study.
Additional file 5: Table S4. Depth information of each allele and each
locus. The short description of the data: Genotypes and average depth,
average depth ratio, and depth per loci of 276 loci obtained by the
9LOCI method.
Additional file 6: Table S5. HLA allele frequency data in Japanese
population. The short description of the data: A list of the HLA allele
frequencies and ranking in the Japanese population.
Additional file 7: Table S6. The number and frequency of HLA alleles
in the Japanese population that were genotyped for the 46 Japanese
reference DNA samples used in this study. The short description of the
data: A list of HLA alleles frequencies in the Japanese population
including the 46 DNA samples used in this study.Abbreviations
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